Header image

GSK Breakfast Symposium: Potential risk and impact of viral infections in patients with cardiovascular disease

Tracks
Arrhythmia / EP
Mechanisms and Preclinical Discovery
Clinical / Surgical
Heart Failure
Imaging
Multidisciplinary
Paediatrics / Adult Congenital
Other
EHJ / HLC
ANZET
Friday, August 2, 2024
7:15 AM - 8:15 AM
Riverview Room 4

Details

Viral infections can pose a significant risk for older adult patients with underlying cardiovascular disease. Professor Tim Tan will outline the burden of disease of RSV (respiratory syncytial virus) and shingles in those with underlying CVD, and the potential impact they could have on your patients. A/Prof Pravin Hissaria will then discuss age-related decline in immunity and the role of vaccination in helping to protect your adult patients against vaccine preventable diseases.


Speaker

Agenda Item Image
Prof Timothy Tan
Consultant Cardiologist
Westmead Hospital / Blacktown Hospitals

Potential risk and impact of viral infections in patients with cardiovascular disease.

Biography

Agenda Item Image
A/Prof Pravin Hissaria
Associate Clinical Professor
Royal Adelaide Hospital

Potential risk and impact of viral infections in patients with cardiovascular disease.

Biography

A/Prof Pravin Hissaria is a Senior Clinical Immunologist at the Royal Adelaide Hospital, Immunopathologist at SA Pathology and an Associate Clinical Professor in the Adelaide University Department of Medicine. He was the Medical Director of COVID vaccination program in SA. He has published several papers on COVID vaccines investigating their safety and efficacy in different vulnerable populations. He has been a member of several national councils, working groups and advisory committees, including the Council of the Australasian Society of Clinical Immunology and Allergy (ASCIA), the Royal College of Pathologists Australia Immunopathology Advisory committee and the ASCIA Drug Allergy working party. He has received grants, authored 98 publications and has given invited talks at national and international meetings, He is the current chair of the SA Therapeutic Immunoglobulin group.
loading